New England Biolabs® Announces the 2023 Donald G. Comb Memorial Lectureship Recipient

IPSWICH, Mass. -- Named in honor of the founder and first Chief Executive Officer of New England Biolabs (NEB®), Donald Comb, this annual lectureship recognizes those who have pioneered basic research, with substantial impact on molecular biology, to address issues affecting the world at large. This year's honoree is Jo Handelsman, the Director of the Wisconsin [...]

Axion BioSystems Welcomes Biotech Industry Leader Julien Bradley as New CEO

ATLANTA -- Axion BioSystems, a leading life science tools company focused on advanced live-cell assay platforms, today announced the appointment of Julien Bradley as the company’s new Chief Executive Officer. With nearly 20 years of experience in biotechnology development, commercialization, and leadership, Bradley will build on Axion’s growth in the fields of stem cell research, immuno-oncology, cell-based therapies, [...]

EXPRESSION SYSTEMS INTRODUCES CHEMICALLY DEFINED INSECT CELL CULTURE MEDIUM FOR SUPERIOR PROTEIN EXPRESSION YIELDS

ESF AdvanCD™ is a 100% chemically defined, animal-origin-free, protein-free, serum-free insect cell culture medium for use in viral vector manufacturing, structural biology and other applications   DAVIS, California – Expression Systems, an Advancion company, today introduced a new, chemically defined cell culture medium that offers exceptional performance while improving the consistency and efficiency of gene therapy and [...]

Shimadzu Introduces the High-Performance, Eco-Friendly, Space-Saving Brevis™ GC-2050 Gas Chromatograph

COLUMBIA, Md. — Shimadzu Scientific Instruments introduces the Brevis™ GC-2050 gas chromatograph with built-in analytical intelligence to deliver best-in-class analytical performance in a space-saving compact design. The eco-friendly Brevis GC-2050 consumes 30% less power than conventional models, minimizes helium gas use and supports alternative carrier gasses. The width of the Brevis GC-2050 system is only 350 [...]

Verily launches Viewpoint Workbench to unify data and accelerate biomedical research

Inaugural partners include Helix, The Michael J. Fox Foundation, and Target ALS SOUTH SAN FRANCISCO, Calif. -- Verily, an Alphabet precision health technology company, has launched Viewpoint Workbench, a new enterprise-grade platform to unify multimodal data and accelerate biomedical research. Workbench provides a secure collaborative environment for data generators, research, and biopharma organizations to govern [...]

Corning Vice Chairman Lawrence D. McRae to Retire After 38 Years with the Company

CORNING. N.Y. -- Corning Incorporated (NYSE: GLW) today announced that its vice chairman and corporate development officer, Lawrence D. McRae, who has been with the company for nearly four decades, will retire at the end of the year. McRae will continue in his current role and remain on Corning’s Senior Leadership Team until his retirement. “Larry has [...]

Cytiva opens new manufacturing facility and experience center in India

The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel therapeutics. According to Cytiva’s 2023 Global Biopharma Resilience Index, the manufacturing of biologics in India is likely to increase over the next three years. Cytiva’s manufacturing facility in [...]

Schauenburg Analytics Ltd announces appointment of new CEO

The Schauenburg Analytics Group (Markes International & SepSolve Analytical) is pleased to announce the appointment of Nigel Fry as its Chief Executive Officer (CEO). As of September 2023, Fry became responsible for all aspects of the business operations of Schauenburg Analytics Ltd and its subsidiaries, Markes International Ltd and SepSolve Analytical Ltd. Fry joins the [...]

Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments

Increased capability to produce medicines for challenging diseases including cancer WALTHAM, Mass. -- Thermo Fisher Scientific, the world leader in serving science, today expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders. Thermo Fisher made a significant investment since 2021 [...]

Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and license agreement with Bayer. Under the terms of the agreement, Twist Biopharma Solutions, a division of Twist Bioscience, will leverage its Library of Libraries to [...]

Access IBO on Knowledge Center